Ibrutinib – Bdbrut 140 Mg

Bdbrut™ is a quality-assured generic of Imbruvica® which is used to treat chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) in adults including those with 17p deletion. It’s also used to treat mantle cell lymphoma (MCL) in adults who have received at least one prior treatment. Furthermore, it’s used to treat marginal zone lymphoma (MZL) in adult patients who require systemic therapy and have received specific prior treatment. Moreover, it’s used to treat Waldenström’s macroglobulinemia (WM) in adults. Additionally, it’s used to treat chronic graft-versus-host disease (cGHVD) after the failure of prior treatment in adults and children.